REFERENCES
- Ministry of Health Directorate-General for Public Health Guide to
COVID-19. Scientific Advisory Board Study 2 August 2020
- Del Rio C, Malani P.N. COVID-19-New insights on a rapidly changing
epidemic. J Am Med Assoc. 2020 Feb 28
- Zhou P, Yang XL, Wang XG, et al. A pneumonia outbreak associated with
a new coronavirus of probable bat origin. Nature. 2020;579
(7798): 270-273.
- YR Cao QD, Hong ZS, et al. The origin transmission and clinical
therapies on coronavirus disease 2019 (COVID-19) outbreak an update on
the status. Mil Med Res. 2020; 7 (1): 11
- Huang C. Wang Y, Li X, et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan. China.
Lancet. 2020; 395 (10223): 497-506.
- Zhu W, Xie K, Lu H, Xu L, Zhou S, Fang S. Initial clinical features of
suspected coronavirus disease 2019 in two emergency departments
outside of Hubei, China. J Med Virol. 2020. 10.1002 / jmv.25763
- Liu Y, Mao B, Liang S, et al. Association between age and clinical
characteristics and outcomes of COVID-19. Eur Respir J 2020; 55:
2001112
- Güneyli S, Atçeken Z, Doğan H, Altınmakas E, Atasoy KÇ. Radiological
approach to COVID-19 pneumonia with an emphasis on chest CT. Diagn
Interv Radiol 2020; 26:323–332.
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138
hospitalized patients with 2019, novel coronavirus-infected pneumonia
in Wuhan. China. JAMA. 2020, 323:1061–1069.
- Baloch S, Baloch MA, Zheng T, Pei X. The Coronavirus Disease 2019
(COVID-19) Pandemic. Tohoku J Exp Med. 2020 Apr;250(4):271-278.
- Aggarwal S, Garcia-Telles N, Aggarwal G, Lavie C, Lippi G, Henry BM.
Clinical features, laboratory characteristics, and outcomes of
patients hospitalized with coronavirus disease 2019 (COVID-19): early
report from the United States. Diagnosis (Berl). 2020;7(2):91-6.
- Guneysu F, Yurumez Y, Guclu E, et al. The diagnostic process of
COVID-19 in the emergency department: laboratory and ımaging
methods. Revista da Associação Médica Brasileira , 2020,66: 2, 58-64
- Li R, Liu G, Huang X, et al. Dynamic changes in clinical and CT
characteristics of COVID-19 cases with different exposure histories: a
retrospective study. BMC Infect Dis. 2020 Aug 3;20(1):567.
- Akcay S, Ozlu T, Yilmaz A. Radiological approaches to COVID-19
pneumonia. Turk J Med Sci (2020) 50: 604-610
- Zhao W, Zhong Z, Xie X, Yu Q, Liu J. Relation between chest CT
findings and clinical conditions of coronavirus disease (COVID-19)
pneumonia: a multicenter study. AJR Am J Roentgenol 2020; 1–6
- Shi H, Han X, Jiang N, et al. Radiological findings from 81 patients
with COVID-19 pneumonia in Wuhan, China: a descriptive study. Lancet
Infect Dis 2020; 20:425–434
- Ai T, Yang Z, Hou H, et al. Correlation of chest CT and RT-PCR testing
in coronavirus disease 2019 (COVID-19) in China: A report of 1014
cases. Radiology 2020 Feb 26
- Li X, Zeng X, Liu B, Yu Y. COVID-19 infection presenting with CT halo
sign. Radiology 2020 Feb 12.
- Franquet T. Imaging of pulmonary viral pneumonia. Radiology 2011;
260:18-39
- Huang C, Wang Y, Li X. et al. Clinical features of patients infected
with 2019 novel coronavirus in Wuhan. China. Lancet.
2020,395:497–506.
- Guan WJ, Ni ZY, Hu Y, et al. Clinical characteristics of coronavirus
disease 2019 in China. N Engl J Med. 2020 382:1708–1720.
- Recalcati S. Cutaneous manifestations in COVID-19: a first
perspective. J Eur Acad Dermatol Venereol. 2020 34:212–213.
- Zhonghua LX, Bing X, Za Z Epidemiology Working Group for Ncip Epidemic
Response CCfDC. Prevention. [The epidemiological characteristics of
an outbreak of 2019 novel coronavirus diseases (COVID19) in China.
2020. 41:145–151.
- Nishiura H, Kobayashi T, Miyama T. et al. Estimation of the
asymptomatic ratio of novel coronavirus infections (COVID-19). Int J
Infect Dis. 2020, 94:154–155.
- Mizumoto K, Kagaya K, Zarebski A, Chowell G. Estimating the
asymptomatic proportion of coronavirus disease 2019. (COVID-19) cases
on board the Diamond Princess cruise ship. Yokohama. Japan. 2020. Euro
Surveill. 2020. 25:2000180.
- Ki M. Task Force for -nCo V. Epidemiologic characteristics of early
cases with 2019 novel coronavirus (2019-nCoV) disease in Korea.
Epidemiol Health. 2020 42:e2020007.
- Lu X, Zhang L, Du H. et al. SARS-CoV-2 Infection in Children. N Engl J
Med. 2020 382:1663–1665.
- Kimball A, Hatfield KM, Arons M, et al. Asymptomatic and
presymptomatic SARS-CoV-2 infections in residents of a long-term care
skilled nursing facility- king county. Washington. March 2020. MMWR
Morb Mortal Wkly Rep. 2020, 69:377– 81.
- Sonmez O. Taşdemir ZA. Kara H V. Akçay S. Tobacco and COVID-19.
Eurasian J Pulmonol 2020;22. Suppl S1:12-5.
- Morse JS, Lalonde T, Xu S, Liu W. Learning from the past: possible
urgent prevention and treatment options for severe acute respiratory
infections Li et al. BMC Infectious Diseases (2020) 20:567 Page 13 of
14 caused by 2019-nCoV. Chembiochem. 2020;21(5):730–738.
- Lu H. Drug treatment options for the 2019-new coronavirus (2019-nCoV).
Biosci TrendsPublished online 28 January. 2020.
- Perego E, Callard F, Stras L, Melville-JÛhannesson B, Pope R, Alwan N.
Why the Patient-Made Term ‘Long Covid’ is needed [version 1; peer
review: awaiting peer review]. Wellcome Open Res. 2020;5,224.
- Greenhalgh T, Knight M, Buxton M, Husain L. Management of post-acute
covid-19 in primary care. Bmj. 2020;370:m3026. 3.
- COVID Symptom Study. How long does COVID-19 last? (blog). London:
Kings College London. https://covid.joinzoe.com/post/covid-long-term
2020. Accessed 1 Oct 2020
- Assaf G, Davis H, McCorkell L, (on behalf of the COVID-19 Body Politic
Slack Group). An Analysis of the Prolonged COVID-19 Symptoms Survey by
Patient-Led Research Team. Patient Led Res. 2020.https://patientresearchcovid19.com/
- Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after
acute COVID-19. JAMA. 2020;324:603–5
- Arnold DT, Hamilton FW, Milne A, et al, Gunning S, Hatrick J, Hamilton
S. Patient outcomes after hospitalisation with COVID-19 and
implications for follow-up; results from a prospective UK cohort.
medRxiv. 2020.
- Goërtz YM, Van Herck M, Delbressine JM, et al. Persistent symptoms 3
months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ
Open Res. 2020;6:00542–2020.
- Vaes AW, Machado FV, Meys R, et al.. Care dependency in
nonhospitalized patients with COVID-19. J Clin Med. 2020;9(9):2946
- Dhont S, Derom E, Van Braeckel E, Depuydt P, Lambrecht BN. The
pathophysiology of ‘happy’ hypoxemia in COVID-19. Respir Res.
2020;21(1):198
- Ladds, E, Rushforth, A, Wieringa, S. et al. Persistent symptoms
after Covid-19: qualitative study of 114 “long Covid” patients and
draft quality principles for services. BMC Health Serv
Res 2020, 20, 1144.
- Tenforde M, Kim S, Lindsell C, et al. Symptom Duration and Risk
Factors for Delayed Return to Usual Health Among Outpatients with
COVID-19 in a Multistate Health Care Systems Network — United
States, March–June 2020. MMWR Morb Mortal Wkly Rep. 2020, ePub: 24
July 2020.
- Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and
rehabilitation needs in survivors of COVID-19 infection: a
cross-sectional evaluation. J Med Virol. 2020;30
- Davido, B., Seang, S., Tubiana, R., & de Truchis, P. Post-COVID-19
chronic symptoms: a postinfectious entity? Clinical microbiology
and infection: the official publication of the European Society of
Clinical Microbiology and Infectious Diseases , 2020, 26 (11),
1448–1449.
- Nikpouraghdam M, Jalali Farahani A, Alishiri G, et al. Epidemiological
characteristics of coronavirus disease 2019 (COVID-19) patients in
Iran: a single center study. J Clin Virol. 2020;127:104378
- Jaillon S, Berthenet K, Garlanda C. Sexual dimorphism in innate
immunity. Clin Rev Allergy Immunol. 2019;56(3):308-21.
- Yao. Y, Cao. J, Wang Q. et al. D-dimer as a biomarker for
disease severity and mortality in COVID-19 patients: a case control
study. j intensive care 2020, 8. 49